相关实验视频
Updated: Feb 4, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
一种基于蛋白质的肺炎球菌疫苗引起了广泛的免疫力,与人类的多功能抗体反应相关
Kaiyi Li1,2, Jinglu Yang1,2, Xiaobing Zhai1
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
一种新的基于蛋白质的肺炎球菌疫苗 (PBPV) 是有前途的,它比传统疫苗提供了更广泛的交叉血清型保护. 虽然免疫反应的持续时间较短,但PBPV针对保存蛋白质,以简化制造和扩大对Streptococcus pneumoniae的覆盖范围.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 传统的Streptococcus pneumoniae疫苗由于病原体多样性而面临限制.
- 基于蛋白质的疫苗提供了一个潜在的替代方案,通过向保存的抗原,独立于血清型.
研究的目的:
- 评估免疫性和多功能抗体对一种新的基于蛋白质的肺炎球菌疫苗 (PBPV) 的反应.
- 为了比较PBPV对23肺炎球菌多糖体疫苗 (23vPPV) 提供的保护范围.
主要方法:
- 评估了抗体反应,包括肺聚素 (Ply) 中和,声细胞活性 (OPA) 和非声功能 (NK细胞激活,抗体依赖性细胞化,中性粒细胞化).
- 在50至69岁的群体中评估了反应.
- 与功能性抗体活动相关的PSPA特异性IgG子类.
主要成果:
- 与23vPPV相比,PBPV诱导了多功能抗体反应,但显示出持久较短的免疫力和降低的Ply-中和能力.
- PBPV提供了更广泛的交叉血清型保护.
- 特定于PSPA的IgG子类 (IgG1,IgG2,IgG3) 在调解OPA,NK细胞激活和细胞发生方面被确定具有明显的作用.
结论:
- PBPV证明了作为一种针对保存的肺炎球菌蛋白的候选疫苗的潜力,提供比多糖疫苗更广泛的覆盖范围.
- 简化制造和扩大覆盖范围是关键优势.
- 需要进一步的研究来证实PBPV的保护效果.
更多相关视频
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
相关概念视频
Vaccinations
Humoral Immune Responses
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...